Simplify Asset Management »

Kalaris Therapeutics shares owned by Simplify Asset Management

Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by Simplify Asset Management from 13F filings

Historical chart of Simplify Asset Management investment in Kalaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kalaris Therapeutics held by Simplify Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalaris Therapeutics by Simplify Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $169k 20k 8.44

More positions owned by Simplify Asset Management

Simplify Exchange Traded Fun Government Money (SBIL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Simplify Exchange Traded Fun Us Eqt Pls Upsid (SPUC)
Simplify Exchange Traded Fun Multi Qis Altern (QIS)
Simplify Exchange Traded Fun Natl Muni Bd Etf (NMB)
Simplify Exchange Traded Fun Aggregate Bond E (AGGH)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Simplify Exchange Traded Fun Next Intangible (NXTI)
Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Regeneron Pharmaceuticals (REGN)
Amgen (AMGN)
Align Technology (ALGN)

View all positions for Simplify Asset Management

Top funds holding Kalaris Therapeutics

Samsara BioCapital
Rtw Investments
Paradigm Biocapital Advisors
Siren
Alyeska Investment Group
Ikarian Capital
Vanguard Group
Woodline Partners
ADAR1 Capital Management
Boothbay Fund Management
Raymond James Financial
Renaissance Technologies
Redmile Group
Geode Capital Management
683 Capital Management

View all funds holding Kalaris Therapeutics